Y-Intercept (HK)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Y-Intercept (HK)’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$129K	Buy	+32,528	New	+$136K	﹤0.01%	1505
2026 Q2	–	Sell	-13,470	Closed	-$47.3K	–	1940
2026 Q1	$47.3K	Buy	+13,470	New	+$55.2K	﹤0.01%	1483
2025 Q2	–	Sell	-39,782	Closed	-$58.5K	–	1811
2025 Q1	$58.5K	Buy	39,782 +24,635	+163%	+$58.7K	﹤0.01%	1127
2024 Q4	$67.1K	Buy	+15,147	New	+$61.5K	﹤0.01%	1114
2024 Q3	–	Sell	-189,962	Closed	-$1.24M	–	1551
2024 Q2	$1.24M	Buy	189,962 +55,346	+41%	+$391K	0.07%	404
2024 Q1	$1.17M	Buy	+134,616	New	+$1.63M	0.09%	322
2023 Q3	–	Sell	-33,396	Closed	-$355K	–	1307
2023 Q2	$355K	Buy	33,396 +4,580	+16%	+$49.2K	0.04%	706
2023 Q1	$303K	Buy	+28,816	New	+$323K	0.04%	770

Other funds holding IRWD

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

OCWP

Owl Creek Wealth Partners Denver, Colorado $355M AUM

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s IRWD Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2026: 32,528 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #1505 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in IRWD as recently as Q1 2026.

Y-Intercept (HK) first reported a position in IRWD in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.24M in Q2 2024. 17 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

Y-Intercept (HK) held 32,528 shares of Ironwood Pharmaceuticals worth $129K as of Q3 2026.
Ironwood Pharmaceuticals was a new Y-Intercept (HK) position in Q3 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1505 holding.
Y-Intercept (HK) first reported a position in Ironwood Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
Y-Intercept (HK)'s Ironwood Pharmaceuticals position peaked at $1.24M in Q2 2024.
17 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.